$科兴生物(SVA)$ SINOVAC is excited to collaborate with Chile's @ucatolica on a clinical trial starting on July 18 (Chile time) for the company's influenza vaccine, the first time SINOVAC has conducted influenza vaccine trials abroad. #influenza #Chile

DR. Dr. Mulya Rahma Karyanti., Pediatricians, Epidemiolog Expert, Cipto Mangunkusumo Hospital Jakarta presented studies showing that SINOVAC #EV71 vaccine in children has good safety and immunogenicity; vaccine efficacy against EV71-associated #HFMD or herpangina was 94.8%.